US Patent Issued to SHANGHAI ENNOVABIO PHARMACEUTICALS on Aug. 19 for "Five-and-six-membered heterocyclic compound and use thereof as protein receptor kinase inhibitor" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,687, issued on Aug. 19, was assigned to SHANGHAI ENNOVABIO PHARMACEUTICALS Co. LTD. (Shanghai).

"Five-and-six-membered heterocyclic compound and use thereof as protein receptor kinase inhibitor" was invented by Lei Jiang (Shanghai), Zhiyong Feng (Shanghai), Xian Jin (Shanghai), Zhi Qiao (Shanghai), Jianyong Shou (Shanghai), Ke Shang (Shanghai), Danyi Wu (Shanghai), Lingling Xu (Shanghai), Yuan Xu (Shanghai), Shuyun Zhang (Shanghai), Yi Zhang (Shanghai) and Yuxing Zhang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "A class of five-membered fused with six-membered heterocyclic compounds represented by formula I and a pharmaceutical composit...